Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 340 followers
Latest posts
Last updated 18 minutes ago
Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
18 minutes ago
This year has seen a growing number of medtechs hit by cyberattacks...
Spyre’s rheumatoid arthritis plan toppled by subpar TL1A data
about 3 hours ago
Phase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis...
SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
about 3 hours ago
SK Biopharmaceuticals has strengthened its epilepsy offering by paying $350 million upfront...
Labcorp launches new hepatitis D test to find patients with most severe form of virus
about 19 hours ago
Labcorp is looking to plug the gap in hepatitis D monitoring with...
Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal
about 22 hours ago
Having set Metsera on its journey to a $10 billion takeover, Arch...
Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'
about 23 hours ago
The “knowledge base is going to start shifting quickly to China,” Rep...
Implantica finally nabs FDA approval 8 years after EU green light for reflux implant
1 day ago
The FDA has signed off on Implantica’s gastroesophageal reflux disease (GERD) implant...
Vacant lab space, shrinking workforce put Mass. in ‘unique position’ for biotech bounceback
1 day ago
A new report on the health of the Massachusetts biotech scene has...
Capricor secures reprieve as FDA extends DMD cell therapy review
1 day ago
The FDA has extended its review of Capricor Therapeutics’ Duchenne muscular dystrophy...
Qiagen appoints new chief executive after 9-month search
2 days ago
Molecular diagnostics specialist Qiagen has a new CEO as Jonathan M. Pratt...
Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug
2 days ago
Spruce Biosciences has taken another step toward filing for FDA approval of...
TME holds onto $1B dream for brain cancer drug as search for partners nears conclusion
2 days ago
TME Pharma’s hunt for a partner for its brain cancer drug is...